Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001992151-25-000004

Chief of Clinical Operations acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Devlin Jodi Chief of Clinical Operations 2025-11-24 Grant or award +50,000 100,571 D
Derivatives
Devlin Jodi Chief of Clinical Operations 2025-11-24 Grant or award · Employee Stock Option (right to buy) +100,000 463,750 D
Loading xslF345X05/wk-form4_1764104159.xml…